Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905148-24-003191
Filing Date
2024-11-14
Accepted
2024-11-14 16:56:18
Documents
3

Document Format Files

Seq Description Document Type Size
1 sadavenbioartiva_13ga1.htm SC 13G/A 175366
2 ex1.htm EX-1 16583
3 ex2.htm EX-2 4510
  Complete submission text file 0000905148-24-003191.txt   198065
Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund III, L.P. (Filed by) CIK: 0001739920 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Subject) CIK: 0001817241 (see all company filings)

EIN.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94570 | Film No.: 241463884
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)